Home > Publications >GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma >

<<Previous Next>>

Post Date:Aug-21-24

GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma

AcceGenAuthor: AcceGen R&D Team

Date Published: 21-Aug-24

  • Authors: Roselia Ciccone, Concetta Quintarelli, Antonio Camera, Michele Pezzella, Simona Caruso, Simona Manni, Alessio Ottaviani, Marika Guercio, Francesca Del Bufalo, Maria Cecilia Quadraccia, Domenico Orlando, Stefano Di Cecca, Matilde Sinibaldi, Mariasole Aurigemma, Laura Iaffaldano, Andrea Sarcinelli, Maria Luisa D’Amore, Manuela Ceccarelli, Francesca Nazio, Veronica Marabitti, Ezio Giorda, Marco Pezzullo, Cristiano De Stefanis, Andrea Carai, Sabrina Rossi, Rita Alaggio, Giada Del Baldo, Marco Becilli, Angela Mastronuzzi, Biagio De Angelis, and Franco Locatelli
  • Journal: Clinical Cancer Research
  • DOI: 10.1158/1078-0432.CCR-23-1880
  • Cited AcceGen Product/Service: Human Schwann Cells

<<Previous Next>>

AcceGen Scroll Top Button